A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus

NCT05411016 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Systemic Lupus Erythematosus (SLE)
Cutaneous Lupus Erythematosus (CLE)

Interventions

DRUG: Placebo
DRUG: KK4277

Sponsor

Kyowa Kirin Co., Ltd.